Beetroot Juice: a Natural Aid for Boosting the Health Benefits of Exercise in Post-menopausal Women?
BEETBOOST
1 other identifier
interventional
60
1 country
1
Brief Summary
Menopause and ageing bring several changes to women's health, partly due to a decline in the hormone estrogen. This reduction affects multiple systems in the body, including muscles and bones, and also influences the production of nitric oxide, a molecule that plays a key role in regulating blood flow and blood pressure. An reduced ability to produce nitric oxide is associated with higher blood pressure and an increased risk of cardiovascular and metabolic diseases. Many women also experience lower levels of physical activity and changes in body composition during midlife, such as increased body fat and reduced muscle mass and strength, which may further decrease exercise capacity. This PhD project investigates whether a simple, natural strategy, combining exercise with beetroot juice, can help postmenopausal women achieve greater benefits from exercise. Beetroot juice is naturally rich in nitrates, which the body can convert into nitric oxide, thereby enhancing blood flow. Exercise itself also stimulates nitric oxide production, and together these approaches may have additive or even synergistic effects. The study examines whether consuming beetroot juice before exercise can enhance training adaptations and health outcomes in postmenopausal women. Key outcomes include cardiovascular function, body composition, musculoskeletal function, and aerobic capacity. Some evidence suggests that beetroot juice may amplify the body's response to exercise, which could be particularly beneficial for postmenopausal women, who often face greater barriers to physical activity. By exploring this combined approach, the project aims to evaluate a safe, non-pharmacological strategy to improve physical function and overall health in women after menopause.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 11, 2026
CompletedFirst Submitted
Initial submission to the registry
March 19, 2026
CompletedFirst Posted
Study publicly available on registry
May 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2033
May 7, 2026
April 1, 2026
3.9 years
March 19, 2026
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure control
Blood pressure control will be assessed using two complementary outcomes: resting (absolute) blood pressure and blood pressure reactivity to standardized stressors. Together, these measures provide insight into both resting and the dynamic regulation of blood pressure in response to physiological challenges. Systolic and diastolic blood pressure will be recorded under standardized conditions using a validated automated device, with multiple readings taken and averaged to improve reliability. Absolute values of systolic and diastolic blood pressure (mmHg) will be used as primary indicators of resting blood pressure control. Blood pressure reactivity will be assessed as the change in mean arterial blood pressure in response to standardized stress tasks (e.g., isometric handgrip exercise and cold-pressor test). Reactivity will be quantified as the difference between baseline resting values and peak blood pressure during the stress task.
Will be measured before (pre) and after (post) 12 weeks of intervention
Secondary Outcomes (2)
Maximal oxygen uptake
Will be measured before and after 12 weeks of intervention
Skeletal muscle strength
Will be measured before (pre) and after (post) 12 weeks of intervention
Study Arms (2)
Nitrate rich
EXPERIMENTALNitrate depleted
PLACEBO COMPARATORInterventions
Intervention includes 3 sessions per week of combined strength and resistance exercise. Two of the sessions are supervised, while the third session is unsupervised-home-based.
Eligibility Criteria
You may qualify if:
- Self-reported biological female and postmenopausal (≥12 months of amenorrhea)
- Aged 50-70 years
- Body mass index (BMI) 25-39.9 kg/m²
- No contraindications to exercise
- Physically inactive (\<150 minutes/week of moderate-intensity activity)
- Able to walk on a treadmill and ambulate without limitations
- Adequate proficiency in Norwegian to complete questionnaires
- Willingness and ability to comply with the study schedule and visits
You may not qualify if:
- Known allergy to nitrates or beetroot juice
- Current smoker or use of nicotine/tobacco products
- Resting blood pressure \<90/60 mmHg
- Hypertension greater than stage II (≥160/100 mmHg, ESH criteria)
- Use of prescription medications affecting heart rate (e.g., systemic β-adrenergic blockers) or nitrate availability (e.g., nitrates, proton pump inhibitors)
- History of cardiovascular disease (e.g., myocardial infarction, stroke, ischemic heart disease, peripheral artery disease, valvular disease, or aortic aneurysm)
- Symptoms suggestive of heart disease (e.g., chest pain or dyspnea)
- Major metabolic disease (e.g., type 1 or type 2 diabetes) or thyroid disorders
- Recent cancer diagnosis or treatment (within the past 5 years)
- Significant orthopedic limitations or other contraindications to exercise
- Diagnosed cognitive impairment
- Planned travel or elective surgery that would interfere with adherence to the intervention
- Psychological or social factors that may interfere with study participation
- Residing beyond a reasonable distance from the study site (logistical constraints)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Western Norway University of Applied Sciences
Bergen, 5063, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ann-Katrin Grotle, PhD
Western Norway University of Applied Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
March 19, 2026
First Posted
May 7, 2026
Study Start
February 11, 2026
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2033
Last Updated
May 7, 2026
Record last verified: 2026-04